Beyond TNF Inhibitors: Latest and Emerging Evidence on Novel Cytokine-Modulating Strategies in the Treatment of Moderate to Severe Psoriasis
0.50 hr(s) | ABIM , CME , CPE , MOC , NCPD
Therapeutic Area(s): Dermatology
Release Date: June 17, 2021
Expiration Date: June 16, 2022
Location: Internet Activity Enduring
In this activity, an expert in dermatology discusses the latest evidence on novel cytokine-modulating strategies in the treatment of moderate to severe psoriasis.